Risk communication and decision-making effectiveness will be measured using the COMRADE scale [ 66].
There is an increasing movement toward the need for cost-effectiveness data in the decision-making process in Europe; for example, health technology assessment procedures in the UK, the Netherlands, Scotland, Sweden, and Portugal all require cost-effectiveness data.
Despite the existence of economic models for supporting decision-making processes in general, for instance cost-benefit and cost-effectiveness analyses, no specific economic models are available in the domain of operational security (including counter-terrorism decision-making) to be applied within the chemical and process industry.
Evidence-based medicine has shifted the paradigm of medical practice by advocating the use of evidence of effectiveness in decision-making for the management of individual patients [ 10].
The type and extent of information available both on the evaluation of relative effectiveness and on decision-making for pharmaceutical coverage varies.
Economic evaluations with cost-effectiveness analyses are important in the decision-making process for health resource allocation.
Therefore, a comprehensively engineered economic model is necessary for the processes that boost natural gas production from depleted wells, which also in turn, guides decision-making processes for operators in their current development plans.
This indicates the need for multiple criteria decision analysis (MCDA) to account for other criteria beyond effectiveness and cost-effectiveness in the decision-making process [ 11- 14].
Decision-making allows for adaptive behavior.
In conclusion, in the current era of budgetary constraints, cost-effectiveness analysis has become increasingly important in decision-making for health resource allocation.
Our results reflected the basics of medical decision-making: combining necessity, effectiveness, safety and economy [ 22].
